IPSEY - Ipsen gains accelerated approval for elafibranor for rare liver disease
2024-06-10 17:33:20 ET
More on Ipsen
- Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors
- Ipsen and Marengo Therapeutics announce second strategic partnership
- Ipsen S.A. reports Q1 results; reaffirms full-year guidance
- Historical earnings data for Ipsen S.A.
- Dividend scorecard for Ipsen S.A.